Advertisement

Topics

Axcella to Present at the Cowen and Company 37th Annual Health Care Conference

07:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Axcella, a biotechnology company pioneering transformative medicines for patients with severe conditions caused by disrupted amino acid biology, announced today that Robert Connelly, President and Chief Executive Officer, will p...

Other Sources for this Article

Media Contact
Ten Bridge Communications
Dan Quinn, 781-475-7974
dan@tenbridgecommunications.com
or
Company Contact
Axcella Health
Thomas Leggett, 857-320-2226
tleggett@axcellahealth.com

NEXT ARTICLE

More From BioPortfolio on "Axcella to Present at the Cowen and Company 37th Annual Health Care Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...